Give the gift of LIFE! Support the Population Research Institute!


Topics: Norplant

Bayer to Stop Selling Controversial Sterilization Device Following Mounting Lawsuits and Complaints

After years of litigation and sustained pressure from thousands of women who have reported injuries and other adverse side effects from the Essure sterilization coil, Bayer, the device’s manufacturer, has announced that it will discontinue selling Essure in the United States by the end of the year. In a press release last Friday, Bayer announced that it would cease selling or distributing Essure after December 31st. Bayer also notified the U.S. Food and Drug Administration …

Read more.

FDA to Review Concerns on the Essure Sterilization Procedure

Reviewing Side Effects of Essure by FDA After receiving thousands of complaints of adverse side-effects, the FDA has decided to conduct a hearing on the safety and effectiveness of Essure. The controversial sterilization implant involves pushing micro coils made of nitinol (a nickel-titanium alloy) and polyethylene terephthalate (PET) fibers into a woman’s fallopian tubes via a hysteroscope and catheter. This scars the fallopian tubes and seals them shut. Originally developed by Conceptus, the Essure system …

Read more.

‘Bahana’ wanted healthcare, they gave her Norplant

•Name and photo are different to protect the woman’s privacy. We need your help… Here at the Population Research Institute we strive to document and expose all the crimes of population control while at the same time debunking the myth of overpopulation. To date, we have uncovered 180 human rights abuses under population control programs in over 50 countries. But in order to continue, we need the support of our generous readers. Read ‘Bahana’s’ story …

Read more.

Woman Reveals Intense Suffering Caused by Norplant Abortifacient

You’re about to read a brief summary of what one Egyptian women experienced when she used Norplant – silicon capsules implanted under the skin that shut down a woman’s reproductive system for up to five years. This is not pleasant reading. This woman’s story – we’ll call her “Bahana” to protect her privacy – is part of an explosive study by an Egyptian-American medical anthropologist who has taught at MIT, Michigan State University, Tufts University …

Read more.

Babies by Remote Control

My long-time English friend, Ann Farmer, has just sent me an interesting article from The Telegraph (London), which tells how all of Scotland is rejoicing at the prospective pregnancy of a captive giant panda. Tests indicate that the female, named Tian Tian (“sweetie”), has conceived but that implantation—that next stage in her pregnancy—is still a few weeks away. At the same time, we have Bill and Melinda Gates, population control enthusiasts extraordinaire, feted for funding …

Read more.

Norplant is Back–Under a Different Name

Ten years ago PRI drove a stake through the heart of Norplant, an abortifacient contraceptive that had harmed thousands of women in the U.S. and many more around the world. But it refused to die.

Read more.

Of Mice and Men: New Study Touts a Male Contraceptive

Radical feminists have long dreamed of “fixing” men, so that women could be relieved of the burden of birth control. Now comes a new study on mice purporting to show that men can be chemically neutered, supposedly without side effects. Male birth control has been the object of much research over the past few decades, but to little avail. Most of the drugs used in trials to stop sperm production also produced unfortunate side effects, …

Read more.

The Head of a Catholic Nonprofit Explains: “Why My Employees Don’t Want Free Birth Control”

In violation of the First Amendment, President Obama has ordered all Catholic nonprofits to provide their employees with so-called “modern methods of birth control.” We at Population Research Institute reject this unlawful “mandate.” Not only does it violate our deeply held religious beliefs, it also violates our mission: to protect and defend innocent unborn life.

Read more.

Never miss an update!

Get our Weekly Briefing! We send out a well-researched, in-depth article on a variety of topics once a week, to large and growing English-speaking and Spanish-speaking audiences.